Pfizer Chief Executive Martin E. Ephron has a total compensation package of $1.4 billion that includes a bonus, stock and restricted stock awards, company stock options, deferred compensation, restricted stock and a bonus.
That total represents a return of more than $1 million a year for Ephrons lifetime, according to the company.
The company also said that Ephons total compensation includes a $500,000 incentive for Pfizer to hire a new chief financial officer.
Etrons compensation includes performance-based incentive plans, according, which also include cash incentives for employees to deliver financial results.
He was the company’s CEO from 2006 through 2016.
EPhron earned $5.6 billion in salary and stock awards in 2016.
He also was paid more than half a billion dollars in other compensation.
The compensation package also includes an incentive payment of $400,000 for the company to expand its U.S. pharmacy network.
Pharmaceuticals giant Pfizer said Wednesday that it is giving Ephones compensation worth $1,500 a share for the next five years.
That’s an increase from the $1 per share that EPhrons pay today.
E Phron earned more than a $3 billion stock award for the past 20 years, according a company spokeswoman.
“Pfizer continues to recognize the value of our outstanding talent and will continue to provide them with additional opportunities and rewards in the future,” the company said in a statement.
Pfizers shares were down 0.5% to $25.65 in midday trading.
